How would you approach a patient with metastatic alveolar rhabdomyosarcoma with progression on first-line therapy?

Progression while on therapy in the setting of initially metastatic rhabdomyosarcoma is a very unfortunate situation for which I would not consider there to be curative options.

The first consideration I would give in this setting is to assess if there are any available clinical trials. If no clinic...